A First in Human Phase 1 Study in Healthy Volunteers and Heterozygous Carriers of a Loss-of-function Granulin Mutation Causative of Frontotemporal Dementia to Assess AL001 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics (AL001-1)
Please go to ClinicalTrials.gov for more information.